Lyanne M. Kieneker

3.1k total citations · 1 hit paper
66 papers, 1.5k citations indexed

About

Lyanne M. Kieneker is a scholar working on Nephrology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lyanne M. Kieneker has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Nephrology, 17 papers in Epidemiology and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lyanne M. Kieneker's work include Chronic Kidney Disease and Diabetes (20 papers), Liver Disease Diagnosis and Treatment (12 papers) and Blood Pressure and Hypertension Studies (11 papers). Lyanne M. Kieneker is often cited by papers focused on Chronic Kidney Disease and Diabetes (20 papers), Liver Disease Diagnosis and Treatment (12 papers) and Blood Pressure and Hypertension Studies (11 papers). Lyanne M. Kieneker collaborates with scholars based in Netherlands, United States and United Kingdom. Lyanne M. Kieneker's co-authors include Stephan J. L. Bakker, Ron T. Gansevoort, Rudolf A. de Boer, Robin P. F. Dullaart, Gerjan Navis, Michel M. Joosten, Setor K. Kunutsor, Jose L. Flores‐Guerrero, Dirk J. van Veldhuisen and Margery A. Connelly and has published in prestigious journals such as The Lancet, Circulation and PLoS ONE.

In The Last Decade

Lyanne M. Kieneker

65 papers receiving 1.4k citations

Hit Papers

Heart Failure Stimulates Tumor Growth by Circulating Factors 2018 2026 2020 2023 2018 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyanne M. Kieneker Netherlands 23 452 304 274 225 216 66 1.5k
Rigas Kalaitzidis Greece 24 537 1.2× 238 0.8× 441 1.6× 204 0.9× 407 1.9× 99 1.7k
Takashi Hisamatsu Japan 21 674 1.5× 211 0.7× 100 0.4× 144 0.6× 179 0.8× 139 1.4k
Richard A. Dart United States 21 638 1.4× 247 0.8× 283 1.0× 189 0.8× 306 1.4× 43 1.5k
R. Neil Dalton United Kingdom 20 326 0.7× 192 0.6× 398 1.5× 179 0.8× 334 1.5× 35 1.4k
Gerjan Navis Netherlands 22 311 0.7× 275 0.9× 480 1.8× 140 0.6× 270 1.3× 60 1.4k
Gerjan Navis Netherlands 26 438 1.0× 315 1.0× 693 2.5× 350 1.6× 586 2.7× 79 2.5k
Jacek Manitius Poland 19 309 0.7× 236 0.8× 639 2.3× 297 1.3× 505 2.3× 122 1.8k
Tanqi Lou China 27 488 1.1× 509 1.7× 947 3.5× 204 0.9× 146 0.7× 93 2.3k
Talia Weinstein Israel 15 233 0.5× 257 0.8× 418 1.5× 181 0.8× 109 0.5× 39 1.4k
Beate Tiran Austria 20 306 0.7× 274 0.9× 164 0.6× 186 0.8× 156 0.7× 67 1.3k

Countries citing papers authored by Lyanne M. Kieneker

Since Specialization
Citations

This map shows the geographic impact of Lyanne M. Kieneker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyanne M. Kieneker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyanne M. Kieneker more than expected).

Fields of papers citing papers by Lyanne M. Kieneker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyanne M. Kieneker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyanne M. Kieneker. The network helps show where Lyanne M. Kieneker may publish in the future.

Co-authorship network of co-authors of Lyanne M. Kieneker

This figure shows the co-authorship network connecting the top 25 collaborators of Lyanne M. Kieneker. A scholar is included among the top collaborators of Lyanne M. Kieneker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyanne M. Kieneker. Lyanne M. Kieneker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kieneker, Lyanne M., Margery A. Connelly, Stephan J. L. Bakker, et al.. (2025). Sex-Specific Determinants of the Ketone Body β-Hydroxybutyrate in the General Population. The Journal of Clinical Endocrinology & Metabolism. 111(4). e995–e1005. 1 indexed citations
2.
Pouwels, Xavier, Lyanne M. Kieneker, Cornelis Boersma, et al.. (2024). Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease. EClinicalMedicine. 68. 102414–102414. 16 indexed citations
3.
Luo, Li, Lyanne M. Kieneker, Roemer J. Janse, et al.. (2024). An increase in albuminuria is associated with a higher incidence of malignancies. Clinical Kidney Journal. 17(3). sfae009–sfae009. 2 indexed citations
4.
Abdulle, Amaal Eman, Lyanne M. Kieneker, Sacha la Bastide‐van Gemert, et al.. (2023). A Sex-Specific Comparative Analysis of Oxidative Stress Biomarkers Predicting the Risk of Cardiovascular Events and All-Cause Mortality in the General Population: A Prospective Cohort Study. Antioxidants. 12(3). 690–690. 3 indexed citations
5.
Luo, Li, Lyanne M. Kieneker, Bert van der Vegt, et al.. (2023). Urinary albumin excretion and cancer risk: the PREVEND cohort study. Nephrology Dialysis Transplantation. 38(12). 2723–2732. 8 indexed citations
6.
Luo, Li, Priya Vart, Lyanne M. Kieneker, et al.. (2023). Mediators of the association between albuminuria and incident cancer: the PREVEND study. Clinical Kidney Journal. 17(1). sfad295–sfad295. 1 indexed citations
7.
Luo, Li, Lyanne M. Kieneker, Roemer J. Janse, et al.. (2023). Albuminuria and the risk of cancer: the Stockholm CREAtinine Measurements (SCREAM) project. Clinical Kidney Journal. 16(12). 2437–2446. 5 indexed citations
8.
Meems, Laura M G, Dirk J. van Veldhuisen, Sven Meyer, et al.. (2022). Sex differences in associations of comorbidities with incident cardiovascular disease: focus on absolute risk. European Heart Journal Open. 2(2). oeac017–oeac017. 5 indexed citations
9.
Groothof, Dion, Adrian Post, Harmke A. Polinder‐Bos, et al.. (2022). Muscle mass and estimates of renal function: a longitudinal cohort study. Journal of Cachexia Sarcopenia and Muscle. 13(4). 2031–2043. 34 indexed citations
10.
Suthahar, Navin, Laura M.G. Meems, Coenraad Withaar, et al.. (2022). Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND. Scientific Reports. 12(1). 147–147. 43 indexed citations
11.
Chia, Yook Chin, Lyanne M. Kieneker, S. Heleen Binnenmars, et al.. (2021). Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population. Journal of the American Heart Association. 10(11). e018549–e018549. 74 indexed citations
12.
Emmens, Johanna E., Jozine M. ter Maaten, Frank P. Brouwers, et al.. (2021). Proenkephalin and the risk of new‐onset heart failure: data from prevention of renal and vascular end‐stage disease. Clinical Cardiology. 44(12). 1662–1672. 4 indexed citations
13.
Osté, Maryse C.J., Jose L. Flores‐Guerrero, Eke G. Gruppen, et al.. (2020). High Plasma Branched-Chain Amino Acids Are Associated with Higher Risk of Post-Transplant Diabetes Mellitus in Renal Transplant Recipients. Journal of Clinical Medicine. 9(2). 511–511. 8 indexed citations
14.
Minović, Isidor, Lyanne M. Kieneker, Ron T. Gansevoort, et al.. (2020). Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study. Nutrients. 12(9). 2711–2711. 12 indexed citations
15.
Klont, Frank, Lyanne M. Kieneker, António W. Gomes‐Neto, et al.. (2020). Female Specific Association of Low Insulin-Like Growth Factor 1 (IGF1) Levels with Increased Risk of Premature Mortality in Renal Transplant Recipients. Journal of Clinical Medicine. 9(2). 293–293. 2 indexed citations
16.
Kunutsor, Setor K., Monika Frysz, Niek Verweij, et al.. (2019). Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study. European Journal of Epidemiology. 35(2). 123–137. 30 indexed citations
17.
Meijer, Esther, Lyanne M. Kieneker, Sofia Enhörning, et al.. (2018). Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population. JCI Insight. 3(13). 38 indexed citations
18.
Kieneker, Lyanne M., Ron T. Gansevoort, Rudolf A. de Boer, et al.. (2016). Urinary potassium excretion and risk of cardiovascular events. American Journal of Clinical Nutrition. 103(5). 1204–1212. 27 indexed citations
19.
Kieneker, Lyanne M., Stephan J. L. Bakker, Rudolf A. de Boer, et al.. (2016). Low potassium excretion but not high sodium excretion is associated with increased risk of developing chronic kidney disease. Kidney International. 90(4). 888–896. 67 indexed citations
20.
Abbasi, Ali, Lyanne M. Kieneker, Eva Corpeleijn, et al.. (2016). Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND Study. Clinical Chemistry. 63(1). 278–287. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026